In an Irish newspaper, doctors have successfully performed the first CT scan of a patient, in an Irish hospital.
Dr David Condon from the Cayuga Medical Center, said he was “very proud” of the “incredible” process of a CT scan in a “very challenging and challenging” situation.
Condon said he is very hopeful that this first case will “help to further strengthen our understanding of the effects of this virus in the brain”.
The patient was in a critical condition and had a very high-risk for brain cancer.
Dr Condon said the first brain scan was carried out in an emergency room and a second scan was done later that day at the hospital.
“We took out a sample of the brain and the CT scan was performed at the Cayugas hospital and it is clear that we did it in a very challenging and difficult situation,” he said.
“It was quite a difficult scan and the patient did not respond at all.”
Dr Corman said the scans showed that the brain had been infected with a virus that can cause severe cognitive impairment.
He said the patient had been in a hospital for a while, but it was the first time he had seen him in the emergency department.
“I was very surprised by his state of mind, his condition,” Dr Condon told the Irish Times.
“He is very much alert and he is having a very good recovery.
It is clear to me that he is a very healthy patient.”
Dr James Dolan, an associate professor at the University of Liverpool who has previously studied the disease, said the initial scans indicated that the virus was likely to have spread from the patient to his family.
“The scan is not perfect but it is very encouraging, especially because of the very limited response from the virus,” he told the paper.
“It was clearly the first case that was actually confirmed to be infected by the virus.”
The virus is spread by direct contact with the saliva of infected people.
Dr Dolan said the scan also revealed the virus in a brain tissue sample, which suggested it could be circulating in the blood stream.
“This is exciting, because we can now use this to try and identify people with an underlying genetic disorder who might have a higher risk of developing brain cancer,” he added.
“But, of course, we can’t say with any certainty what the exact risk of this is and what the long-term effects of the virus are, but this is encouraging.”
The patient’s family had also been advised to check their immunisation records, which could have alerted doctors to the risk of infection.
Dr Christopher Murphy, an infectious diseases expert from St Andrews University, said more research was needed before any predictions could be made about the potential long- term effects of exposure to the virus.
“These results may have a small effect but it could lead to a number of patients in the future developing the same risk of disease,” he warned.
“People are at risk from infection and they need to be fully informed about their immunisations.”